F18 PSMA imaging – A viable option

Posted on: 29 May 2016Clinical,Latest News

Prostate imaging presentation at ANZSNM 2016

Australia and New Zealand Society for Nuclear Medicine (ANZSNM) 2016 Annual Meeting was held April 22-25, in Rotorua New Zealand.

A number of speakers addressed the issue of prostate cancer imaging, with a variety of techniques and PET tracers.

A presentation by Cyclotek Clinical Director Dr Rob Ware reviewed a number of recent studies with Gallium-68 and Fluorine-18 labeled tracers. Rob also outlined some of the practical issues as they pertain to Australia and New Zealand, including logistics and GMP compliance.

A copy of Rob’s presentation titled “F18 PSMA imaging – A viable option” is available below


[contact-form-7 id=”714″ title=”Update Form”]